Andrés Celestino
García Montero
Profesor Asociado
Hospital Clínico San Carlos de Madrid
Madrid, EspañaPublicaciones en colaboración con investigadores/as de Hospital Clínico San Carlos de Madrid (9)
2023
-
Mast Cell Activation Syndromes: Comparison Between Two Scoring Models to Predict for Mast Cell Clonality
The journal of allergy and clinical immunology. In practice, Vol. 11, Núm. 3, pp. 908-919
2019
-
Genetic association between CD96 locus and immunogenicity to anti-TNF therapy in Crohn’s disease
Pharmacogenomics Journal, Vol. 19, Núm. 6, pp. 547-555
-
Genetic variation at the glycosaminoglycan metabolism pathway contributes to the risk of psoriatic arthritis but not psoriasis
Annals of the Rheumatic Diseases, Vol. 78, Núm. 3, pp. 355-364
2016
-
A genome-wide association study identifies SLC8A3 as a susceptibility locus for ACPA-positive rheumatoid arthritis
Rheumatology (United Kingdom), Vol. 55, Núm. 6, pp. 1106-1111
-
Identification of IRX1 as a Risk Locus for Rheumatoid Factor Positivity in Rheumatoid Arthritis in a Genome-Wide Association Study
Arthritis and Rheumatology, Vol. 68, Núm. 6, pp. 1384-1391
-
Urine metabolome profiling of immune-mediated inflammatory diseases
BMC Medicine, Vol. 14, Núm. 1
2015
-
Identification of risk loci for crohn's disease phenotypes using a genome-wide association study
Gastroenterology, Vol. 148, Núm. 4, pp. 794-805
2013
-
A genome-wide association study on a southern European population identifies a new Crohn's disease susceptibility locus at RBX1-EP300
Gut, Vol. 62, Núm. 10, pp. 1440-1445
2008
-
Safety and effectiveness of immunotherapy in patients with indolent systemic mastocytosis presenting with Hymenoptera venom anaphylaxis
Journal of Allergy and Clinical Immunology, Vol. 121, Núm. 2, pp. 519-526